Try GOLD - Free
Does US cancer drug nod make Cipla attractive?
Mint Chennai
|April 18, 2025
Cipla, which makes HIV, respiratory and cancer drugs, is targeting North America with generic launches
Cipla Ltd's shares have surged 6% since last week when it announced the final approval from the US Food and Drug Administration for its generic version of Bristol Myers Squibb's Abraxane, a cancer drug. Does the approval to sell the much-awaited product in the US make Cipla a compelling buy, especially when Trump's tariffs loom?
"One product approval by itself doesn't suddenly make a company more attractive," said Prashant Nair, lead analyst for pharma and healthcare at Ambit Capital. "Earlier-than-expected approval for Abraxane is positive, but tariffs will have a bearing on Cipla."
This story is from the April 18, 2025 edition of Mint Chennai.
Subscribe to Magzter GOLD to access thousands of curated premium stories, and 10,000+ magazines and newspapers.
Already a subscriber? Sign In
MORE STORIES FROM Mint Chennai
Mint Chennai
Roll back quality control orders on inputs to spur manufacturing
Such QCOs hold back the competitiveness of manufacturers and ending them could catapult our factory sector to a new orbit
4 mins
November 18, 2025
Mint Chennai
'Many blitzscaling startups don't transition to discipline'
overthe last decade havescaled much more than anyone anticipated.
1 mins
November 18, 2025
Mint Chennai
'GST reforms to boost urban demand'
Homegrown fast-moving consumer goods (FMCG) major Marico Ltd expects India’s urban demand, especially in categories such as packaged foods, to perk up in the coming quarters aided by tailwinds from the recently-cut goods and services tax rates.
2 mins
November 18, 2025
Mint Chennai
China, India throw oil a lifeline as global glut looms
Global oil markets may be dominated by concerns about a glut, but producers have found some support in buying from China and India, spurred by awave of US sanctions on Russian energy.
1 mins
November 18, 2025
Mint Chennai
Apple boosts R&D on iPhone materials, says design chief
Creating proprietary materials took precedence over supply chain costs, says Richard Dinh
3 mins
November 18, 2025
Mint Chennai
Govt seeks time in SC on Sahara, Adani land sale petition
The Union government has sought more time to file its response to a plea by financially-stressed Sahara India Commercial Corporation Ltd (SICCL), which is seeking the Supreme Court’s nod to sell 88 properties, including Aamby Valley in Maharashtra and Sahara Shaher in Lucknow, to Adani Properties Pvt. Ltd in a ₹12,000-crore deal, and pay off its debts.
1 min
November 18, 2025
Mint Chennai
Welspun to sell majority in clean energy firm, hires EY
Company targets equity value of $100 million for stake in Welspun New Energy
2 mins
November 18, 2025
Mint Chennai
Infosys rolls out Al-first GCC model
T major Infosys on Monday introduced an AI-first model aimed at speeding up the establishment and transformation of global capability centres into AI-driven hubs that promote innovation and growth.
1 min
November 18, 2025
Mint Chennai
Trump's bets on China and Argentina are souring fast
When it comes to US foreign economic polic policy, President Donald Trump’s administration has two problems on its hands.
3 mins
November 18, 2025
Mint Chennai
Rural demand drives FMCG growth in September quarter
India’s fast-moving consumer goods (FMCG) sector reported a 5.4% rise in September-quarter volumes, which moderated sequentially on account of disruptions related to the transition to new goods and services tax rates, while the value of sales jumped 12.9%, according to data released by consumer intelligence platform NielsenIQ.
1 mins
November 18, 2025
Listen
Translate
Change font size